Mass production of the ginsenoside Rg3(S) through the combinative use of two glycoside hydrolases

Food Chemistry

Volumn 141, Issue 2, 2013, Pages 1369-1377

  Kim, Jin Kwang ^a,c   Cui, Chang Hao ^a   Liu, Qingmei ^a,b   Yoon, Min Ho ^c   Kim, Sun Chang ^a,b   Im, Wan Taek ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b Intelligent Synthetic Biology Center   (South Korea)

^c Chungnam National University   (South Korea)

Author keywords

Biotransformation; Mass production; L arabinofuranosidase; Glucosidase

Indexed keywords

ENZYMES; HYDROLASES; SUGARS;

ARABINOFURANOSIDASE; BIOTRANSFORMATION; CONVERSION REACTIONS; ENZYMATIC BIOCONVERSIONS; GLUCOSIDASE; GLYCOSIDE HYDROLASES; MASS PRODUCTION; PHARMACEUTICAL INDUSTRY;

GLYCOSIDES;

GINSENOSIDE RB 1; GINSENOSIDE RC; GINSENOSIDE RD; GINSENOSIDE RG 3; GLYCOSIDASE;

ARTICLE; BIOREACTOR; BIOTRANSFORMATION; DEGLYCOSYLATION; DRUG INDUSTRY; ENZYME CHEMISTRY; ENZYME SPECIFICITY; FLAVOBACTERIUM JOHNSONIAE; FUNCTIONAL FOOD; LEUCONOSTOC; PH; TEMPERATURE;

PANAX GINSENG;

EID: 84878389522     PISSN: 03088146     EISSN: 18737072     Source Type: Journal    
DOI: 10.1016/j.foodchem.2013.04.012     Document Type: Article

References (35)

1. An, D. S., Cui, C. H., Lee, H. G., Wang, L., Kim, S. C., Lee, S. T., et al. (2010). Identification and characterization of a novel Terrabacter ginsenosidimutans sp. nov. β-glucosidase that transforms ginsenoside Rb1 into the rare gypenosides XVII and LXXV. Applied and Environmental Microbiology, 76(17), 5827-5836.
2. T. Applied Microbiology and Biotechnology, 94(3), 673-682.
3. An, D. S., Wang, L., Kim, M. S., Bae, H. M., Lee, S. T., & Im, W. T. (2011). Solirubrobacter ginsenosidimutans sp. nov., isolated from soil of a ginseng field. International Journal of Systematic and Evolutionary Microbiology, 61(11), 2606-2609.
4. Attele, A. S., Wu, J. A., & Yuan, C. S. (1999). Ginseng pharmacology: multipl (Pubitemid 29505408)
5. Chang, K. H., Jee, H. S., Lee, N. K., Park, S. H., Lee, N. W., & Paik, H. D. (2009). Optimization of the enzymatic production of 20(S)-ginsenoside Rg3 from white ginseng extract using response surface methodology. New Biotechnology, 26(3-4), 181-186.
6. 3 by Microbacterium sp. GS514. Phytochemistry, 69(1), 218-224. (Pubitemid 350256793)
7. Choi, K. T. (2008). Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C.A. Meyer. Acta Pharmacologica Sinica, 29(9), 1109-1118.
8. Cui, C. H., Kim, S. C., & Im, W. T. (2013). Characterization of the ginsenosidetransforming recombinant beta-glucosidase from Actinosynnema mirum and bioconversion of major ginsenosides into minor ginsenosides. Applied Microbiology and Biotechnology, 97(2), 649-659.
9. Han, B. H., Park, M. H., Han, Y. N., Woo, L. K., Sankawa, U., Yahara, S., et al. (1982). Degradation of ginseng saponins under mild acidic conditions. Planta Medicine, 44(3), 146-149. (Pubitemid 12101117)
10. 2 by recombinant β-glucosidase from Flavobacterium johnsoniae. Journal of Ginseng Research, 36(4), 418-424.
11. Hwang, J. T., Lee, M. S., Kim, H. J., Sung, M. J., Kim, H. Y., Kim, M. S., et al. (2009). Antiobesity effect of ginsenoside Rg3 involves the AMPK and PPAR-gamma signal pathways. Phytotherpy Research, 23(2), 262-266.
12. Iishi, H., Tatsuta, M., Baba, M., Uehara, H., Nakaizumi, A., et al. (1997). Inhibition by ginsenoside Rg3 of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats. Clinical and Experimental Metastasis, 15(6), 603-611. (Pubitemid 27435741)
13. In, J. G., Kim, E. J., Lee, B. S., Park, M. H., & Yang, D. C. (2006). Saponin analysis and red ginseng production using the simplified method of Korean ginseng (Panax ginseng C.A. Meyer). Korean Journal of Plant Research, 19(1), 133-138.
14. Jia, L., & Zhao, Y. (2009). Current evaluation of the millennium phytomedicineginseng (I): Etymology, pharmacognosy, phytochemistry, market and regulations. Current Medicinal Chemistry, 16(19), 2475-2484.
15. Keum, Y. S., Han, S. S., Chun, K. S., Park, K. K., Park, J. H., Lee, S. K., et al. (2003). Inhibitory effects of the ginsenoside Rg3 on phorbol ester-induced cyclooxygenase-2 expression, NF-kappaB activation and tumor promotion. Mutation Research, 523-524, 75-85. (Pubitemid 36293234)
16. 1 using novel recombinant ginsenoside hydrolyzing glycosidase cloned from Sanguibacter keddieii and enzyme characterization. Journal of Biotechnology, 161(3), 294-301.
17. Kim, H. S., Lee, E. H., Ko, S. R., Choi, K. J., Park, J. H., & Im, D. S. (2004). Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells. Archives of Pharmacal Research, 27(4), 429-435.
18. Kim, J. Y., Wang, Y., Park, S. J., Ji, G. E., & Park, M. S. (2012b). Cloning and expression of β-glucosidases from Bifidobacterium lactis AD011. Food Science and Biotechnology, 21(3), 731-738.
19. Ko, S. K., Lee, K. H., Hong, J. K., Kang, S. A., Sohn, U. D., Im, B. O., et al. (2005). Change of ginsenoside composition in ginseng extract by vinegar process. Food Science and Biotechnology, 14(4), 509-513.
20. Korea Food & Drug Administration (KFDA). Production record of health functional food and analysis result of that in 2011 [Seoul, Korea]. Lee, F. C. (1992). Facts about ginseng, the elixir of life. Elizabeth, NJ: Hollyn International Corp.
21. Lee, J. H., Hyun, Y. J., & Kim, D. H. (2011). Cloning and characterization of α-Larabinofuranosidase and bifunctional α-L-arabinopyranosidase/β-Dgalactopyranosidase from Bifidobacterium longum H-1. Journal of Applied Microbiology, 111(5), 1097-1107.
22. Lee, S. Y., Kim, G. T., Roh, S. H., Song, J. S., Kim, H. J., Hong, S. S., et al. (2009). Proteomic analysis of the anti-cancer effect of 20S-ginsenoside Rg3 in human colon cancer cell lines. Bioscience Biotechnology Biochemistry, 73(4), 811-816.
23. Liu, Q. M., Jung, H. M., Cui, C. H., Sung, B. H., Kim, J. K., Kim, S. G., et al. (2013). Bioconversion of ginsenoside Rc into Rd by a novel α-L-arabinofuranosidase, Abf22-3 from Leuconostoc sp. 22-3: Cloning, expression, and enzyme characterization. Antonie van Leeuwenhoek, 2013(103), 747-754.
24. Luan, H., Hu, Y., Liu, X., Hao, D., & Yang, L. (2008). Purification and characterization of a beta-D-xylosidase from Leifsonia shinshuensis DICP 16. Sheng Wu Gong Cheng Xue Bao, 24(5), 867-873.
25. Mochizuki, M., Yoo, Y. C., Matsuzawa, K., Sato, K., Saiki, I., Tonooka, S., et al. (1995). Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)-and 20(S)-ginsenoside-Rg3, of red ginseng. Biological and Pharmaceutical Bulletin, 18(9), 1197-1202.
26. Nam, K. Y. (2005). The comparative understanding between red ginseng and white ginsengs processed ginsengs (Panax ginseng C.A. Meyer). Journal of Ginseng Research, 29(1), 1-18.
27. Park, J. H. (2004). Sun ginseng-A new processed ginseng with fortified activity. Food Industry and Nutrition, 9, 23-27.
28. Park, J. D., Rhee, D. K., & Lee, Y. H. (2005). Biological activities and chemistry of saponins from Panax ginseng C.A. Meyer. Phytochemistry Review, 4, 159-175. (Pubitemid 41752174)
29. Qi, L. W., Wang, C. Z., & Yuan, C. S. (2011). Ginsenosides from American ginseng: Chemical and pharmacological diversity. Phytochemistry, 72(8), 689-699.
30. 3 by recombinant βglucosidase from Microbacterium esteraromaticum. Applied Microbiology and Biotechnology, 94(2), 377-384.
31. Sun, L. Q. (2004). Information on research and application of ginseng, the king of traditional and herbal medicines. Asian Journal of Drug Metabolism and Pharmacokinetics, 4(4), 261-284.
32. Tian, J., Zhang, S., Li, G., Liu, Z., & Xu, B. (2009). 20(S)-ginsenoside Rg3, a neuroprotective agent, inhibits mitochondrial permeability transition pores in rat brain. Phytotherapy Research, 23(4), 486-491.
33. Wang, L., An, D. S., Kim, S. G., Jin, F. X., Kim, S. C., Lee, S. T., et al. (2012). Ramlibacter ginsenosidimutans sp. nov., with ginsenoside-converting activity. Journal of Microbiology and Biotechnology, 22(3), 311-315.
34. 2, Rc and Rd by novel beta-glucosidase hydrolyzing outer 3-O glycoside from Sphingomonas sp. 2F2: Cloning, expression, and enzyme characterization. Journal of Biotechnology, 156(2), 125-133.
35. 3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer. Chinese Medical Journal (English Edition), 120(7), 584-588. (Pubitemid 46629914)